| 1 |
Tariq R, Syed T, Yadav D, Prokop LJ, Singh S, Loftus EV Jr, Pardi DS, Khanna S. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis. J Clin Gastroenterol 2023;57:285-93. [PMID: 34864789 DOI: 10.1097/MCG.0000000000001633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Gu X, Chen ZH, Zhang SC. Fecal microbiota transplantation in childhood: past, present, and future. World J Pediatr 2022;:1-10. [PMID: 36484871 DOI: 10.1007/s12519-022-00655-w] [Reference Citation Analysis]
|
| 3 |
Li Q, Zhou S, Wang Y, Cong J. Changes of intestinal microbiota and microbiota-based treatments in IBD. Arch Microbiol 2022;204:442. [PMID: 35776212 DOI: 10.1007/s00203-022-03069-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Yue Q, Cai M, Xiao B, Zhan Q, Zeng C. The Microbiota–Gut–Brain Axis and Epilepsy. Cell Mol Neurobiol 2022;42:439-453. [DOI: 10.1007/s10571-021-01130-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 5 |
Sannathimmappa MB, Nambiar V, Aravindakshan R. Antibiotics at the crossroads - Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance? J Educ Health Promot 2021;10:438. [PMID: 35071644 DOI: 10.4103/jehp.jehp_557_21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 6 |
Pratap Mouli V, Ahuja V. Microbiota Based Management of the Gastrointestinal Disorders. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00011-5] [Reference Citation Analysis]
|
| 7 |
Lamprinos Michailidis, Alden C. Currier, Michelle Le, Deborah R. Flomenhoft. Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies. Ann Gastroenterol 2021;34. [PMID: 34815646 DOI: 10.20524/aog.2021.0655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Gholam-Mostafaei FS, Yadegar A, Asadzadeh Aghdaei H, Shahrokh S, Ebrahimi Daryani N, Zali MR. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis. Acta Microbiol Immunol Hung 2021. [PMID: 34383708 DOI: 10.1556/030.2021.01498] [Reference Citation Analysis]
|
| 9 |
Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 107] [Cited by in F6Publishing: 82] [Article Influence: 53.5] [Reference Citation Analysis]
|
| 10 |
Sehgal K, Yadav D, Khanna S. The interplay of Clostridioides difficile infection and inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211020285. [PMID: 34104215 DOI: 10.1177/17562848211020285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Mehta SR, Yen EF. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy. Transl Res 2021;230:197-207. [PMID: 33278650 DOI: 10.1016/j.trsl.2020.11.013] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Qianqian Yao, Huiying Li, Linlin Fan, Yangdong Zhang, Shengguo Zhao, Nan Zheng, Jiaqi Wang. Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease. Foods 2021;10:368. [PMID: 33567698 DOI: 10.3390/foods10020368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol 2021;18:67-80. [PMID: 32843743 DOI: 10.1038/s41575-020-0350-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 27.5] [Reference Citation Analysis]
|
| 14 |
Craig Haifer, Rupert W Leong, Sudarshan Paramsothy. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Curr Opin Pharmacol 2020;55. [PMID: 33035780 DOI: 10.1016/j.coph.2020.08.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 15 |
Khoruts A, Hoffmann DE, Palumbo FB. The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation. J Law Med Ethics 2019;47:482-504. [PMID: 31957587 DOI: 10.1177/1073110519897726] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 16 |
Grigoryan Z, Shen MJ, Twardus SW, Beuttler MM, Chen LA, Bateman-House A. Fecal microbiota transplantation: Uses, questions, and ethics. Med Microecol 2020;6:100027. [PMID: 33834162 DOI: 10.1016/j.medmic.2020.100027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Zhao HL, Chen SZ, Xu HM, Zhou YL, He J, Huang HL, Xu J, Nie YQ. Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis. J Dig Dis 2020;21:534-48. [PMID: 33439534 DOI: 10.1111/1751-2980.12933] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 18 |
Tan P, Li X, Shen J, Feng Q. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update. Front Pharmacol. 2020;11:574533. [PMID: 33041818 DOI: 10.3389/fphar.2020.574533] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 19 |
You JHS, Jiang X, Lee WH, Chan PKS, Ng SC. Cost‐effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2020;35:1515-1523. [DOI: 10.1111/jgh.15002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 20 |
Haifer C, Kelly CR, Paramsothy S, Andresen D, Papanicolas LE, Mckew GL, Borody TJ, Kamm M, Costello SP, Andrews JM, Begun J, Chan HT, Connor S, Ghaly S, Johnson PD, Lemberg DA, Paramsothy R, Redmond A, Sheorey H, van der Poorten D, Leong RW. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 2020;69:801-810. [DOI: 10.1136/gutjnl-2019-320260] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 21 |
Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020;72:1003-1027. [DOI: 10.1016/j.jhep.2020.01.017] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 22 |
Yao M, Xie J, Du H, Mcclements DJ, Xiao H, Li L. Progress in microencapsulation of probiotics: A review. Comprehensive Reviews in Food Science and Food Safety 2020;19:857-74. [DOI: 10.1111/1541-4337.12532] [Cited by in Crossref: 116] [Cited by in F6Publishing: 124] [Article Influence: 38.7] [Reference Citation Analysis]
|
| 23 |
Kumar V, Fischer M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opinion on Biological Therapy 2020;20:73-81. [DOI: 10.1080/14712598.2020.1689952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 24 |
Azimirad M, Yadegar A, Gholami F, Shahrokh S, Asadzadeh Aghdaei H, Ianiro G, Suzuki H, Cammarota G, Zali MR. Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease. J Inflamm Res 2020;13:563-70. [PMID: 32982371 DOI: 10.2147/JIR.S265520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Elangovan A, Allegretti JR, Fischer M. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opinion on Biological Therapy 2019;19:1343-1355. [DOI: 10.1080/14712598.2019.1673725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 26 |
Allegretti JR, Mullish BH, Kelly C, Fischer M. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet 2019;394:420-31. [PMID: 31379333 DOI: 10.1016/S0140-6736(19)31266-8] [Cited by in Crossref: 182] [Cited by in F6Publishing: 176] [Article Influence: 45.5] [Reference Citation Analysis]
|
| 27 |
Wang Z, Qi Q. Gut microbial metabolites associated with HIV infection. Future Virol 2019;14:335-47. [PMID: 31263508 DOI: 10.2217/fvl-2019-0002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 28 |
Robert P Hirten, Ari Grinspan, Shih-Chen Fu, Yuying Luo, Mayte Suarez-Farinas, John Rowland, Eduardo J Contijoch, Ilaria Mogno, Nancy Yang, Tramy Luong, Philippe R Labrias, Inga Peter, Judy H Cho, Bruce E Sands, Jean Frederic Colombel, Jeremiah J Faith, Jose C Clemente. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25. [PMID: 30852592 DOI: 10.1093/ibd/izy398] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 29 |
Nikolas Dovrolis, Eirini Filidou, George Kolios. Systems biology in inflammatory bowel diseases: on the way to precision medicine. Ann Gastroenterol 2019;32. [PMID: 31040620 DOI: 10.20524/aog.2019.0373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Kyeong Ok Kim, Michael Gluck. Fecal Microbiota Transplantation: An Update on Clinical Practice. Clin Endosc 2019;52. [PMID: 30909689 DOI: 10.5946/ce.2019.009] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 24.8] [Reference Citation Analysis]
|
| 31 |
Abu-sbeih H, Ali FS, Wang Y. Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients. Curr Gastroenterol Rep 2019;21:8. [DOI: 10.1007/s11894-019-0677-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 32 |
Maseda D, Zackular JP, Trindade B, Kirk L, Roxas JL, Rogers LM, Washington MK, Du L, Koyama T, Viswanathan VK, Vedantam G, Schloss PD, Crofford LJ, Skaar EP, Aronoff DM. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response. mBio 2019;10. [PMID: 30622186 DOI: 10.1128/mBio.02282-18] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 33 |
Newman KM, Moscoso CG, Vaughn BP. Fecal Microbiota Transfer and Inflammatory Bowel Disease. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications 2019. [DOI: 10.1016/b978-0-12-815249-2.00045-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 34 |
Krajicek E, Fischer M, Allegretti JR, Kelly CR. Nuts and Bolts of Fecal Microbiota Transplantation. Clinical Gastroenterology and Hepatology 2019;17:345-352. [DOI: 10.1016/j.cgh.2018.09.029] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 35 |
Alexander N. Levy, Jessica R. Allegretti. Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284819836893. [PMID: 30906424 DOI: 10.1177/1756284819836893] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 36 |
Srishti Saha, Sahil Khanna. Management of Clostridioides difficile colitis: insights for the gastroenterologist. Therap Adv Gastroenterol 2019;12:1756284819847651. [PMID: 31105766 DOI: 10.1177/1756284819847651] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 37 |
Staley C, Kaiser T, Khoruts A. Clinician Guide to Microbiome Testing. Dig Dis Sci 2018;63:3167-77. [PMID: 30267172 DOI: 10.1007/s10620-018-5299-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 38 |
Paknikar R, Pekow J. Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection. Surg Infect (Larchmt). 2018;19:785-791. [PMID: 30300561 DOI: 10.1089/sur.2018.221] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 39 |
Anthony P. Corfield. The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human. Microorganisms 2018;6:78. [PMID: 30072673 DOI: 10.3390/microorganisms6030078] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 40 |
Jeon SR, Chai J, Kim C, Lee CH. Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation. Curr Infect Dis Rep 2018;20:21. [DOI: 10.1007/s11908-018-0627-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 41 |
Chen T, Zhou Q, Zhang D, Jiang F, Wu J, Zhou J, Zheng X, Chen Y. Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies. Journal of Crohn's and Colitis 2018;12:710-717. [DOI: 10.1093/ecco-jcc/jjy031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 42 |
Hirten RP, Grinspan A, Fu S, Luo Y, Suarez-farinas M, Rowland J, Contijoch EJ, Mogno I, Yang N, Luong T, Labrias PR, Peter I, Cho JH, Sands BE, Colombel JF, Faith JJ, Clemente JC. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium difficile Patients With and Without IBD.. [DOI: 10.1101/267492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 43 |
Allegretti JR, Kassam Z, Osman M, Budree S, Fischer M, Kelly CR. The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointestinal Endoscopy 2018;87:18-29. [DOI: 10.1016/j.gie.2017.05.036] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 44 |
Tran V, Phan J, Nulsen B, Huang L, Kaneshiro M, Weiss G, Ho W, Sack J, Ha C, Uslan D, Sauk JS. Severe Ileocolonic Crohnʼs Disease Flare Associated with Fecal Microbiota Transplantation Requiring Diverting Ileostomy. ACG Case Reports Journal 2018;5:e971-4. [DOI: 10.14309/02075970-201805120-00013] [Reference Citation Analysis]
|
| 45 |
Patel K, Patel A, Hawes D, Shah J, Shah K. Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease. Gastroenterol Hepatol Bed Bench 2018;11:1-8. [PMID: 29564058] [Reference Citation Analysis]
|
| 46 |
Tran V, Phan J, Nulsen B, Huang L, Kaneshiro M, Weiss G, Ho W, Sack J, Ha C, Uslan D, Sauk JS. Severe Ileocolonic Crohnʼs Disease Flare Associated with Fecal Microbiota Transplantation Requiring Diverting Ileostomy: . ACG Case Reports Journal 2018;5:e97. [DOI: 10.14309/02075970-201805000-00097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 47 |
Staley C, Khoruts A, Sadowsky MJ. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. Archives of Medical Research 2017;48:766-773. [DOI: 10.1016/j.arcmed.2017.11.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 48 |
Kelly CR, Allegretti JR. FMT in IBD: What Have We Learned? Dig Dis Sci 2017;62:2618-20. [PMID: 28840580 DOI: 10.1007/s10620-017-4713-9] [Reference Citation Analysis]
|
| 49 |
Thaiss CA, Elinav E. The remedy within: will the microbiome fulfill its therapeutic promise? J Mol Med 2017;95:1021-1027. [DOI: 10.1007/s00109-017-1563-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 50 |
Ribeiro ABDTM, Heimesaat MM, Bereswill S. Changes of the Intestinal Microbiome-Host Homeostasis in HIV-Infected Individuals - A Focus on the Bacterial Gut Microbiome. Eur J Microbiol Immunol (Bp) 2017;7:158-67. [PMID: 29034105 DOI: 10.1556/1886.2017.00016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 51 |
D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003 [PMID: 28785153 DOI: 10.3748/wjg.v23.i27.4986] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 52 |
He Z, Cui BT, Zhang T, Li P, Long CY, Ji GZ, Zhang FM. Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report. World J Gastroenterol 2017; 23(19): 3565-3568 [PMID: 28596693 DOI: 10.3748/wjg.v23.i19.3565] [Cited by in CrossRef: 130] [Cited by in F6Publishing: 132] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 53 |
Nelson A, Tsai HH. Editorial: Clostridium difficile and inflammatory bowel disease - is it always a bad combination? Aliment Pharmacol Ther 2017;45:1368-9. [PMID: 28417498 DOI: 10.1111/apt.14039] [Reference Citation Analysis]
|
